The current price of EHC is $137.21 — it has decreased by 2.87% since the previous close. Data as of Nov 6, 2026.
EHC is up 1.99% over the past week, up 10.04% over the past month and up 19.24% over the past year. The price is above its 200-day moving average of $110.81.
Analysts' average 12-month price target for EHC is $154.86, which implies 12.86% upside from the current price. Individual estimates range from $150.00 to $165.00.
Of the 13 analysts covering Encompass Health Corporation, 1 rates it a strong buy and 12 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Encompass Health Corporation has a market capitalization of $13.54B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Yes. Encompass Health Corporation pays dividends quarterly. The latest payment of $0.21 per share has a payment date of Jan 15, 2027, which corresponds to a dividend yield of 0.58%.
In the latest trading session EHC moved between $136.94 and $139.56, a range of 1.91% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Encompass Health Corporation shows a buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks EHC has traded between $92.77 and $143.36. The current price is 4.29% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.